[1]
M. Rajpoot, D. Singh, K. . Pandey, and R. Bhargava, “Safety and efficacy of cyclosporine (0.05% versus 0.09%) in dry eye disease. Is it the strength of cyclosporin that really matters? ”, Nep J Oph, vol. 14, no. 2, pp. 64–77, Dec. 2022.